Method for down-regulating IL5 activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2007
Grant Date -
N/A
app pub date -
Apr 19, 2000
filing date -
Apr 23, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Improvements in therapy and prevention of conditions characterized by an elevated level of eosinophil leukocytes, i.e. conditions such as asthma and other chronic allergic diseases are disclosed. A method is provided for down-regulating interleukin 5 (IL5) by enabling the production of antibodies against IL5 thereby reducing the level of activity of eosinophils.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully